Data / Drug companies / Guaifenesin/phenylephrine
Guaifenesin/phenylephrine: 7 companies and 7 products in the FDA NDC directory
Guaifenesin/phenylephrine is listed in the FDA National Drug Code Directory by 7 companies, with 7 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, and the newest product started marketing on January 27, 2023.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 7
- Products
- 7
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 1
- Routes
- Oral
- Brand names
- Sunmark Chest Congestion Relief Pe Pe, Foster and Thrive Chest Congestion Relief Pe Pe, Rugby Chest Congestion Relief Pe, GNP Mucus Relief Pe, CVS Health Chest Congestion Relief Pe, Topcare Chest Congestion and Sinus Congestion Relief Pe, Always Save Mucus Relief Pe
- openFDA record search
- api.fda.gov
Companies that list guaifenesin/phenylephrine
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Amerisource Bergen | 1 | tablet | Over the counter monograph drugs | January 13, 2022 |
| CVS Pharmacy | 1 | tablet | Over the counter monograph drugs | June 5, 2006 |
| Rugby Laboratories | 1 | tablet | Over the counter monograph drugs | September 9, 2020 |
| Strategic Sourcing Services LLC | 1 | tablet | Over the counter monograph drugs | June 5, 2006 |
| Strategic Sourcing Services LLC | 1 | tablet | Over the counter monograph drugs | January 27, 2023 |
| Topco Associates LLC | 1 | tablet | Over the counter monograph drugs | June 5, 2006 |
| Valu Merchandisers Company | 1 | tablet | Over the counter monograph drugs | August 18, 2021 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 7 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 7 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Expectorant | 7 |
| alpha-1 Adrenergic Agonist | 7 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.